These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
715 related articles for article (PubMed ID: 27733182)
1. An Xp11.2 translocation renal cell carcinoma with SMARCB1 (INI1) inactivation in adult end-stage renal disease: a case report. Yu L; Li J; Xu S; Navia Miranda M; Wang G; Duan Y Diagn Pathol; 2016 Oct; 11(1):98. PubMed ID: 27733182 [TBL] [Abstract][Full Text] [Related]
2. TFE3 break-apart FISH has a higher sensitivity for Xp11.2 translocation-associated renal cell carcinoma compared with TFE3 or cathepsin K immunohistochemical staining alone: expanding the morphologic spectrum. Rao Q; Williamson SR; Zhang S; Eble JN; Grignon DJ; Wang M; Zhou XJ; Huang W; Tan PH; Maclennan GT; Cheng L Am J Surg Pathol; 2013 Jun; 37(6):804-15. PubMed ID: 23598965 [TBL] [Abstract][Full Text] [Related]
3. PSF/SFPQ is a very common gene fusion partner in TFE3 rearrangement-associated perivascular epithelioid cell tumors (PEComas) and melanotic Xp11 translocation renal cancers: clinicopathologic, immunohistochemical, and molecular characteristics suggesting classification as a distinct entity. Rao Q; Shen Q; Xia QY; Wang ZY; Liu B; Shi SS; Shi QL; Yin HL; Wu B; Ye SB; Li L; Chen JY; Pan MH; Li Q; Li R; Wang X; Zhang RS; Yu B; Ma HH; Lu ZF; Zhou XJ Am J Surg Pathol; 2015 Sep; 39(9):1181-96. PubMed ID: 26274027 [TBL] [Abstract][Full Text] [Related]
4. Utilization of a TFE3 break-apart FISH assay in a renal tumor consultation service. Green WM; Yonescu R; Morsberger L; Morris K; Netto GJ; Epstein JI; Illei PB; Allaf M; Ladanyi M; Griffin CA; Argani P Am J Surg Pathol; 2013 Aug; 37(8):1150-63. PubMed ID: 23715164 [TBL] [Abstract][Full Text] [Related]
5. Xp11.2 translocation renal neoplasm with features of TFE3 rearrangement associated renal cell carcinoma and Xp11 translocation renal mesenchymal tumor with melanocytic differentiation harboring NONO-TFE3 fusion gene. Yu W; Wang Y; Rao Q; Jiang Y; Zhang W; Li Y Pathol Res Pract; 2019 Sep; 215(9):152521. PubMed ID: 31277953 [TBL] [Abstract][Full Text] [Related]
6. RBM10-TFE3 Renal Cell Carcinoma: A Potential Diagnostic Pitfall Due to Cryptic Intrachromosomal Xp11.2 Inversion Resulting in False-negative TFE3 FISH. Argani P; Zhang L; Reuter VE; Tickoo SK; Antonescu CR Am J Surg Pathol; 2017 May; 41(5):655-662. PubMed ID: 28296677 [TBL] [Abstract][Full Text] [Related]
7. Molecular cytogenetic analysis for TFE3 rearrangement in Xp11.2 renal cell carcinoma and alveolar soft part sarcoma: validation and clinical experience with 75 cases. Hodge JC; Pearce KE; Wang X; Wiktor AE; Oliveira AM; Greipp PT Mod Pathol; 2014 Jan; 27(1):113-27. PubMed ID: 23828314 [TBL] [Abstract][Full Text] [Related]
8. TMED6-COG8 is a novel molecular marker of TFE3 translocation renal cell carcinoma. Xu Y; Rao Q; Xia Q; Shi S; Shi Q; Ma H; Lu Z; Chen H; Zhou X Int J Clin Exp Pathol; 2015; 8(3):2690-9. PubMed ID: 26045774 [TBL] [Abstract][Full Text] [Related]
9. SFPQ/PSF-TFE3 renal cell carcinoma: a clinicopathologic study emphasizing extended morphology and reviewing the differences between SFPQ-TFE3 RCC and the corresponding mesenchymal neoplasm despite an identical gene fusion. Wang XT; Xia QY; Ni H; Ye SB; Li R; Wang X; Shi SS; Zhou XJ; Rao Q Hum Pathol; 2017 May; 63():190-200. PubMed ID: 28315422 [TBL] [Abstract][Full Text] [Related]
10. A case of bilateral renal cell carcinoma associated with long-term dialysis showing false-positive immunoreactivity for TFE3 as Xp11 translocation renal cell carcinoma. Kurisaki-Arakawa A; Saito T; Takahashi M; Mitani K; Fukumura Y; Nagashima Y; Argani P; Yao T Int J Clin Exp Pathol; 2013; 6(11):2585-90. PubMed ID: 24228124 [TBL] [Abstract][Full Text] [Related]
11. Validation and utilization of a TFE3 break-apart FISH assay for Xp11.2 translocation renal cell carcinoma and alveolar soft part sarcoma. Pradhan D; Roy S; Quiroga-Garza G; Cieply K; Mahaffey AL; Bastacky S; Dhir R; Parwani AV Diagn Pathol; 2015 Sep; 10():179. PubMed ID: 26415891 [TBL] [Abstract][Full Text] [Related]
12. Xp11 Translocation Renal Cell Carcinomas (RCCs) With RBM10-TFE3 Gene Fusion Demonstrating Melanotic Features and Overlapping Morphology With t(6;11) RCC: Interest and Diagnostic Pitfall in Detecting a Paracentric Inversion of TFE3. Xia QY; Wang XT; Zhan XM; Tan X; Chen H; Liu Y; Shi SS; Wang X; Wei X; Ye SB; Li R; Ma HH; Lu ZF; Zhou XJ; Rao Q Am J Surg Pathol; 2017 May; 41(5):663-676. PubMed ID: 28288037 [TBL] [Abstract][Full Text] [Related]
13. Melanotic Translocation Renal Cell Carcinoma With a Novel ARID1B-TFE3 Gene Fusion. Antic T; Taxy JB; Alikhan M; Segal J Am J Surg Pathol; 2017 Nov; 41(11):1576-1580. PubMed ID: 28877054 [TBL] [Abstract][Full Text] [Related]
14. TFE3-Fusion Variant Analysis Defines Specific Clinicopathologic Associations Among Xp11 Translocation Cancers. Argani P; Zhong M; Reuter VE; Fallon JT; Epstein JI; Netto GJ; Antonescu CR Am J Surg Pathol; 2016 Jun; 40(6):723-37. PubMed ID: 26975036 [TBL] [Abstract][Full Text] [Related]
15. Melanotic Xp11 translocation renal cancer: report of a case with a unique intratumoral sarcoid-like reaction. Ritterhouse LL; Cykowski MD; Hassell LA; Slobodov G; Bane BL Diagn Pathol; 2014 Apr; 9():81. PubMed ID: 24735727 [TBL] [Abstract][Full Text] [Related]
16. RBM10-TFE3 renal cell carcinoma characterised by paracentric inversion with consistent closely split signals in break-apart fluorescence in-situ hybridisation: study of 10 cases and a literature review. Kato I; Furuya M; Baba M; Kameda Y; Yasuda M; Nishimoto K; Oyama M; Yamasaki T; Ogawa O; Niino H; Nakaigawa N; Yano Y; Sakamoto K; Urata Y; Mikami K; Yamasaki S; Tanaka R; Takagi T; Kondo T; Nagashima Y Histopathology; 2019 Aug; 75(2):254-265. PubMed ID: 30908700 [TBL] [Abstract][Full Text] [Related]
17. ALK rearrangement in TFE3-positive renal cell carcinoma: Alternative diagnostic option to exclude Xp11.2 translocation carcinoma. Zhu Y; Liu N; Guo W; Pu X; Guo H; Gan W; Li D Pathol Res Pract; 2020 Dec; 216(12):153286. PubMed ID: 33197836 [TBL] [Abstract][Full Text] [Related]
18. A novel partner of TFE3 in the Xp11 translocation renal cell carcinoma: clinicopathological analyses and detection of EWSR1-TFE3 fusion. Fukuda H; Kato I; Furuya M; Tanaka R; Takagi T; Kondo T; Nagashima Y Virchows Arch; 2019 Mar; 474(3):389-393. PubMed ID: 30552521 [TBL] [Abstract][Full Text] [Related]
19. Xp11.2 translocation renal cell carcinoma with PSF-TFE3 rearrangement. Zhong M; Weisman P; Zhu B; Brassesco M; Yang Y; Linehan WM; Merino MJ; Zhang D; Rohan S; Cai D; Yang X Diagn Mol Pathol; 2013 Jun; 22(2):107-11. PubMed ID: 23628822 [TBL] [Abstract][Full Text] [Related]
20. A rare case of TFE-related pigmented renal tumor with overlapping features between melanotic Xp11 translocation renal cancer and Xp11 renal cell carcinoma with melanotic features. Cardili L; Wrublevsky Pereira G; Viana CR Pathol Int; 2017 Apr; 67(4):208-213. PubMed ID: 28208226 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]